Laurie Stelzer Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Laurie Stelzer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Laurie Stelzer. Laurie Stelzer is EVP & Chief Financial Officer in ARENA PHARMACEUTICALS INC ($ARNA) and Chief Financial Officer in HALOZYME THERAPEUTICS INC ($GYHT) and SVP, CFO in HALOZYME THERAPEUTICS INC ($GYHT) and SVP, Chief Financial Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Surface Oncology, Inc. ($SURF).
Latest Insider Trading Transactions of Laurie Stelzer
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARNA, GYHT, PMVP, SURF
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Stelzer Laurie | Director | Option Exercise | A | 32.29 | 16,333 | 527,393 | 16,333 | |
| Apr 02 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 12,600 | 0 | 0 | |
| Apr 02 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Payment of Exercise | F | 76.10 | 4,356 | 331,492 | 14,904 | 19.3 K to 14.9 K (-22.62 %) |
| Apr 02 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Buy | M | 0.00 | 12,600 | 0 | 19,260 | 6.7 K to 19.3 K (+189.19 %) |
| Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
| Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
| Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Grant | A | 0.00 | 6,660 | 0 | 6,660 | 0 to 6.7 K |
| Jun 12 2020 | SURF | Surface Oncology, ... | Stelzer Laurie | Director | Option Exercise | A | 4.35 | 12,000 | 52,200 | 12,000 | |
| Mar 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 6,300 | 0 | 6,300 | |
| Mar 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | A | 36.33 | 132,000 | 4,795,560 | 132,000 | |
| Feb 24 2020 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 11,392 | 0 | 11,392 | |
| Feb 24 2020 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 21.83 | 4,508 | 98,410 | 116,167 | 120.7 K to 116.2 K (-3.74 %) |
| Feb 24 2020 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 11,392 | 0 | 120,675 | 109.3 K to 120.7 K (+10.42 %) |
| Feb 13 2020 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 11,262 | 0 | 0 | |
| Feb 13 2020 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 20.00 | 3,894 | 77,880 | 104,174 | 108.1 K to 104.2 K (-3.60 %) |
| Feb 13 2020 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 11,262 | 0 | 108,068 | 96.8 K to 108.1 K (+11.63 %) |
| Feb 12 2020 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 0.00 | 32,533 | 0 | 32,533 | |
| Feb 12 2020 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 19.98 | 69,174 | 1,382,097 | 69,174 | |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 23,119 | 0 | 0 | |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 19.21 | 8,275 | 158,963 | 96,806 | 105.1 K to 96.8 K (-7.87 %) |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 23,119 | 0 | 105,081 | 82 K to 105.1 K (+28.21 %) |
| Jun 17 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 6,875 | 0 | 0 | |
| Jun 17 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 15.73 | 3,408 | 53,608 | 81,962 | 85.4 K to 82 K (-3.99 %) |
| Jun 17 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 6,875 | 0 | 85,370 | 78.5 K to 85.4 K (+8.76 %) |
| Jun 06 2019 | SURF | Surface Oncology, ... | Stelzer Laurie | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
| Jun 06 2019 | SURF | Surface Oncology, ... | Stelzer Laurie | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
| Feb 22 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 11,392 | 0 | 22,784 | |
| Feb 22 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 16.81 | 3,939 | 66,215 | 78,495 | 82.4 K to 78.5 K (-4.78 %) |
| Feb 22 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 11,392 | 0 | 82,434 | 71 K to 82.4 K (+16.04 %) |
| Feb 15 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 7,809 | 0 | 23,425 | |
| Feb 15 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 16.54 | 2,700 | 44,658 | 71,042 | 73.7 K to 71 K (-3.66 %) |
| Feb 15 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 7,809 | 0 | 73,742 | 65.9 K to 73.7 K (+11.84 %) |
| Feb 14 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 0.00 | 45,046 | 0 | 45,046 | |
| Feb 14 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 16.65 | 85,922 | 1,430,601 | 85,922 | |
| Feb 05 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 23,119 | 0 | 23,119 | |
| Feb 05 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 16.12 | 8,317 | 134,070 | 65,933 | 74.3 K to 65.9 K (-11.20 %) |
| Feb 05 2019 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 23,119 | 0 | 74,250 | 51.1 K to 74.3 K (+45.22 %) |
| Feb 23 2018 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 11,392 | 0 | 34,176 | |
| Feb 23 2018 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 19.28 | 3,939 | 75,944 | 47,510 | 51.4 K to 47.5 K (-7.66 %) |
| Feb 23 2018 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 11,392 | 0 | 51,449 | 40.1 K to 51.4 K (+28.44 %) |
| Feb 16 2018 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 0.00 | 31,234 | 0 | 31,234 | |
| Feb 16 2018 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 18.41 | 54,780 | 1,008,500 | 54,780 | |
| Feb 05 2018 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 23,120 | 0 | 46,238 | |
| Feb 05 2018 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 18.37 | 8,265 | 151,828 | 40,057 | 48.3 K to 40.1 K (-17.10 %) |
| Feb 05 2018 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 23,120 | 0 | 48,322 | 25.2 K to 48.3 K (+91.74 %) |
| Jun 16 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 6,875 | 0 | 13,750 | |
| Jun 16 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 13.05 | 2,583 | 33,708 | 25,202 | 27.8 K to 25.2 K (-9.30 %) |
| Jun 16 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 6,875 | 0 | 27,785 | 20.9 K to 27.8 K (+32.88 %) |
| Feb 24 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 0.00 | 45,568 | 0 | 45,568 | |
| Feb 24 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 12.07 | 72,925 | 880,205 | 72,925 | |
| Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 23,120 | 0 | 69,358 | |
| Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 12.26 | 9,085 | 111,382 | 20,910 | 30 K to 20.9 K (-30.29 %) |
| Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 23,120 | 0 | 29,995 | 6.9 K to 30 K (+336.29 %) |
| Jun 16 2016 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 6,875 | 0 | 20,625 | |
| Jun 16 2016 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 6,875 | 0 | 16,875 | 10 K to 16.9 K (+68.75 %) |
| Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 92,478.00 | 92,478 | 8,552,180,484 | 92,478 | |
| Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 8.11 | 104,603 | 848,330 | 104,603 | |
| Aug 24 2015 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | Chief Financial Off ... | Buy | P | 17.24 | 10,000 | 172,384 | 10,000 | 0 to 10 K |
| Jun 16 2015 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, CFO | Option Exercise | A | 0.00 | 27,500 | 0 | 27,500 | |
| Jun 16 2015 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, CFO | Option Exercise | A | 20.43 | 225,000 | 4,596,750 | 225,000 |
Page: 1